[{"address1": "Level 10", "address2": "Tower 11 Avenue 5, No. 8 Jalan Kerinchi", "city": "Kuala Lumpur", "zip": "592000", "country": "Malaysia", "phone": "60 9 08517 7330", "website": "https://www.cyclacel.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Sing Ee Wong", "age": 43, "title": "Chairman, CEO & President", "yearBorn": 1981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Cu Seng Kiu", "age": 34, "title": "Executive Director, CFO & Secretary", "yearBorn": 1990, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gill  Christie", "age": 67, "title": "Director of Human Resources", "yearBorn": 1957, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Grace  Kim", "title": "Investor Relations Executive", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 17.15, "open": 15.96, "dayLow": 15.5401, "dayHigh": 17.9999, "regularMarketPreviousClose": 17.15, "regularMarketOpen": 15.96, "regularMarketDayLow": 15.5401, "regularMarketDayHigh": 17.9999, "payoutRatio": 0.0, "beta": 0.038, "trailingPE": 0.37129632, "forwardPE": -8.060302, "volume": 454097, "regularMarketVolume": 454097, "averageVolume": 1831819, "averageVolume10days": 10091180, "averageDailyVolume10Day": 10091180, "bid": 0.0, "ask": 17.35, "bidSize": 0, "askSize": 1, "marketCap": 25406720, "fiftyTwoWeekLow": 3.08, "fiftyTwoWeekHigh": 597.6, "priceToSalesTrailing12Months": 1814.7657, "fiftyDayAverage": 12.5844, "twoHundredDayAverage": 76.3656, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 20375576, "profitMargins": 0.0, "floatShares": 139648, "sharesOutstanding": 1583960, "sharesShort": 123114, "sharesShortPriorMonth": 39674, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0777, "heldPercentInsiders": 0.61492, "heldPercentInstitutions": 0.06637, "shortRatio": 0.03, "shortPercentOfFloat": 0.1593, "impliedSharesOutstanding": 1583960, "bookValue": 3.544, "priceToBook": 4.52596, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -8347000, "trailingEps": 43.2, "forwardEps": -1.99, "lastSplitFactor": "1:15", "lastSplitDate": 1751846400, "enterpriseToRevenue": 1455.398, "enterpriseToEbitda": -1.607, "52WeekChange": -0.95899796, "SandP52WeekChange": 0.16932249, "lastDividendValue": 0.15, "lastDividendDate": 1745884800, "quoteType": "EQUITY", "currentPrice": 16.04, "recommendationKey": "none", "totalCash": 3450000, "totalCashPerShare": 2.324, "ebitda": -12679500, "totalDebt": 9000, "quickRatio": 5.204, "currentRatio": 5.602, "totalRevenue": 14000, "debtToEquity": 0.294, "revenuePerShare": 0.016, "returnOnAssets": -1.6018, "returnOnEquity": -19.50234, "grossProfits": 14000, "freeCashflow": -11783125, "operatingCashflow": -10754000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -906.0714, "financialCurrency": "USD", "symbol": "CYCC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -6.4723, "regularMarketPrice": 16.04, "marketState": "CLOSED", "shortName": "Cyclacel Pharmaceuticals, Inc.", "longName": "Cyclacel Pharmaceuticals, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1079447400000, "postMarketChangePercent": 0.136523, "corporateActions": [], "postMarketTime": 1753487911, "regularMarketTime": 1753473601, "exchange": "NCM", "messageBoardId": "finmb_125004", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "postMarketPrice": 16.0619, "postMarketChange": 0.0218983, "regularMarketChange": -1.11, "regularMarketDayRange": "15.5401 - 17.9999", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1831819, "fiftyTwoWeekLowChange": 12.960001, "fiftyTwoWeekLowChangePercent": 4.2077928, "fiftyTwoWeekRange": "3.08 - 597.6", "fiftyTwoWeekHighChange": -581.56, "fiftyTwoWeekHighChangePercent": -0.9731593, "fiftyTwoWeekChangePercent": -95.899796, "dividendDate": 1746057600, "earningsTimestamp": 1747284600, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "earningsCallTimestampStart": 1723667400, "earningsCallTimestampEnd": 1723667400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 43.2, "epsForward": -1.99, "fiftyDayAverageChange": 3.4556007, "fiftyDayAverageChangePercent": 0.274594, "twoHundredDayAverageChange": -60.3256, "twoHundredDayAverageChangePercent": -0.78995776, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Cyclacel Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]